Chiusura precedente | 36,99 |
Aperto | 37,28 |
Denaro | 37,40 x 1300 |
Lettera | 38,65 x 1300 |
Min-Max giorno | 37,22 - 37,90 |
Intervallo di 52 settimane | 26,48 - 50,64 |
Volume | |
Media Volume | 2.097.442 |
Capitalizzazione | 8,245B |
Beta (5 anni mensile) | 0,93 |
Rapporto PE (ttm) | N/D |
EPS (ttm) | -4,34 |
Prossima data utili | 08 mag 2023 - 12 mag 2023 |
Rendimento e dividendo (forward) | 0,56 (1,52%) |
Data ex dividendo | 30 mar 2023 |
Stima target 1A | 40,00 |
CHARLOTTE, N.C., March 06, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced that it has entered into an accelerated share repurchase agreement (the “ASR”) with Goldman Sachs & Co. LLC to repurchase $150 million of its common stock. The ASR agreement will be completed under Dentsply Sirona’s current share repurchase authorization. Under the terms of the ASR, Dentsply Sirona will initially receive delivery of approximately 3.1 millio
FY22 net sales decreased (7.3%) to $3,922 million, organic sales decreased (0.5%)FY22 GAAP EPS of ($4.41), adjusted EPS of $2.09Q4 net sales decreased (10.9%) to $983 million, organic sales decreased (2.6%)Q4 GAAP EPS of ($0.07), adjusted EPS of $0.46FY23 outlook: net sales of $3.85 - $3.95 billion, organic sales down (1%) to up 2%, adj. EPS range of $1.80 to $2.00 CHARLOTTE, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today an
Expects to Achieve $200 to $225 million in Annual Cost Savings Portfolio Evaluation and Simplification Plan Ongoing CHARLOTTE, N.C., Feb. 16, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced that its Board of Directors approved an organizational restructuring plan intended to improve operational performance and drive shareholder value creation. The plan is anticipated to achieve at least $200 million in annual cost savings over the